Will CVS Health Stock Recover?
It’s been a treacherous journey for CVS Health Corporation (NYSE:CVS)…
Sell
4
ORKA Quote, Financials, Valuation and Earnings
Last price:
$12.24
Seasonality move
:
--
Day range:
$12.24 - $13.00
52-week range:
$12.24 - $31.13
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
1.26x
Volume:
185.1K
Avg. volume:
376.5K
1-year change:
--
Market cap:
$428.7M
Revenue:
--
EPS (TTM):
--
Earnings Data
Next earnings date for ORKA
Jan 23
2025
Most recent earnings per share
-$1.46
Missed by $1.14
(Nov 13/2024)
Consensus Estimate
-$0.32
(Nov 13/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
ORKA Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 04/01/2025 | Q1 | -- | -- | -- | -$0.31 | -- |
| 01/23/2025 | Q4 | -- | -- | -- | -$0.98 | -- |
| 11/13/2024 | Q3 | -- | -- | -$1.46 | -$0.32 | -$1.14 |
| 06/30/2024 | Q2 | -- | -- | -$0.76 | -- | -- |
Oruka Therapeutics Earnings Questions
-
How Much did Oruka Therapeutics Generate in Revenue Last Quarter?
Oruka Therapeutics reported -- worth of top line sales in its most recent quarter.
-
Did Oruka Therapeutics Beat Earnings Last Quarter?
Oruka Therapeutics announced earnings per share of -$1.46 which represents a miss of analyst forecast a -$0.32 per share.
-
Is Oruka Therapeutics Profitable?
Oruka Therapeutics reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Oruka Therapeutics EPS Next Year?
Oruka Therapeutics's earnings are forecast to grow from -- per share to -$3.95 per share next year representing an increase of --.
-
When is Oruka Therapeutics's Earnings Date?
Oruka Therapeutics's next earnings date is January 23, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is AT&T Stock Dropping?
The telecommunications giant AT&T Inc. (NYSE:T) has perhaps surprisingly eclipsed…
Is American Express Stock Going Lower?
American Express Company (NYSE:AXP) has long been a Buffett favorite…
Stock Ideas
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 38x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 115x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Alerts
Sell
45
QMCO alert for Jan 18
Quantum [QMCO] is down 15.61% over the past day.
Buy
51
QRVO alert for Jan 18
Qorvo [QRVO] is up 14.47% over the past day.
Sell
31
ATEX alert for Jan 18
Anterix [ATEX] is up 11.14% over the past day.
